Suppr超能文献

用于头孢地尼、头孢他美、头孢美唑、头孢泊肟、头孢达肟(RU29246,HR - 916代谢物)和曲氟沙星纸片扩散药敏试验的嗜血杆菌检测培养基解释标准。

Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.

作者信息

Jones R N, Erwin M E

机构信息

Department of Pathology, University of Iowa College of Medicine, Iowa City 52242.

出版信息

Diagn Microbiol Infect Dis. 1992 Nov-Dec;15(8):693-701. doi: 10.1016/0732-8893(92)90073-3.

Abstract

The disk diffusion zones and the MICs of six newer antimicrobials with significant activity against Haemophilus influenzae were compared using the Haemophilus test medium (HTM) and National Committee for Clinical Laboratory Standards methods. The rank order of potency was cefpodoxime (MIC50, < or = 0.03 micrograms/ml) > cefetamet > cefdinir > cefdaloxime = trospectomycin > cefmetazole (MIC50, 2 micrograms/ml). Susceptible breakpoint interpretive criteria for HTM tests were established that conformed to prior recommendations for each drug when tested against other species. Absolute agreement between methods ranged from 89% to 100% with < or = 1% false-susceptible interpretive errors. The recommended, tentative disk diffusion susceptible interpretive criteria were for 5-micrograms cefdinir disks > or = 20 mm (MIC correlate, < or = 1 micrograms/ml); for 10-micrograms cefetamet disks > or = 18 mm (MIC correlate, < or = 4 micrograms/ml); for 30-micrograms cefetamet disks > or = 21 mm (MIC correlate, < or = 4 micrograms/ml); for 30-micrograms cefmetazole disks > or = 16 mm (MIC correlate, < or = 16 micrograms/ml); for 10-micrograms cefpodoxime disks > or = 21 mm (MIC correlate, < or = 2 micrograms/ml); for 30-micrograms cefdaloxime disks > or = 23 mm (MIC correlate, < or = 2 micrograms/ml) and for 30-micrograms trospectomycin disks > or = 17 mm (MIC correlate, < or = 16 micrograms/ml). beta-Lactamase-negative, ampicillin-resistant (BLNAR) H. influenzae isolates consistently had the highest MICs for each cephalosporin tested.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

使用嗜血杆菌测试培养基(HTM)和美国国家临床实验室标准委员会的方法,比较了六种对流感嗜血杆菌具有显著活性的新型抗菌药物的纸片扩散法抑菌圈和最低抑菌浓度(MIC)。效力的排序为头孢泊肟(MIC50,≤0.03微克/毫升)>头孢他美酯>头孢地尼>头孢达肟 = 曲氟沙星>头孢美唑(MIC50,2微克/毫升)。建立了HTM测试的敏感折点解释标准,该标准在针对其他菌种测试时符合每种药物先前的建议。两种方法之间的绝对一致性范围为89%至100%,假敏感解释错误≤1%。推荐的、暂定的纸片扩散法敏感解释标准为:5微克头孢地尼纸片≥20毫米(MIC对应值,≤1微克/毫升);10微克头孢他美酯纸片≥18毫米(MIC对应值,≤4微克/毫升);30微克头孢他美酯纸片≥21毫米(MIC对应值,≤4微克/毫升);30微克头孢美唑纸片≥16毫米(MIC对应值,≤16微克/毫升);10微克头孢泊肟纸片≥21毫米(MIC对应值,≤2微克/毫升);30微克头孢达肟纸片≥23毫米(MIC对应值,≤2微克/毫升);30微克曲氟沙星纸片≥17毫米(MIC对应值,≤16微克/毫升)。对每种测试的头孢菌素,β-内酰胺酶阴性、氨苄西林耐药(BLNAR)的流感嗜血杆菌分离株始终具有最高的MIC。(摘要截短于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验